Advanced Gastric or Gastro-Esophageal Cancers

Advanced Gastric or Gastro-Esophageal Cancers

Episodes

Specialty:

All

Year:

All

EP. 1: Introduction and Global Trends of Gastric Cancer

July 18th 2019

EP. 2: Genetic Risk, Screening, and Diagnosis for Gastric Cancer

July 18th 2019

EP. 3: Molecular Testing Used for Gastric Cancer

July 18th 2019

EP. 4: Factors Determining Initial Treatment Approach for Gastric Cancer

July 18th 2019

EP. 5: Treatment in HER2-Positive Disease and Dosing Preferences

July 18th 2019

EP. 6: First-Line Therapy in HER2-Negative Gastric Cancer

July 18th 2019

EP. 7: Trastuzumab in HER2-Positive Gastroesophageal Cancer

July 18th 2019

EP. 8: Surgery Options in Locally Advanced Gastric Cancer

July 18th 2019

EP. 9: Differentiating Among the Types of Surgery

July 18th 2019

EP. 10: Place for Surgery and Poor Prognosis

July 18th 2019

EP. 11: Ramucirumab for Progressive Disease in Gastric Cancer

July 18th 2019

EP. 12: The Role of Immunotherapy in Gastric Cancer

July 18th 2019

EP. 13: Interpretation of Data on Immunotherapy Use in Gastric Cancer

July 18th 2019

EP. 14: Novel and Combination Therapies for the Treatment of Gastric Cancer

July 18th 2019

EP. 15: Drug Development and Final Thoughts

July 18th 2019

Trending on OncLive

CLL Treatment Individualization Prompts Changes in Patient Evaluation and Care

Japan Approves Subcutaneous Pembrolizumab for All Approved Pembrolizumab Indications

FDA Grants Fast Track Designation to LYT-200 in R/R High-Risk MDS

Integrating Bispecific Antibodies Into Frontline Therapy for Newly Diagnosed Multiple Myeloma

NAPISTAR-1-01 Data Support Rapid TUB-040 Development in Biomarker-Unrestricted Ovarian Cancer